Literature DB >> 6234659

Protein S and the regulation of activated protein C.

F J Walker.   

Abstract

The studies that have been carried out to date suggest that protein S can function as a cofactor protein in the activated protein C catalyzed inactivation of Factor Va. This conclusion is supported by the observation that protein S and activated protein C can form a lipid bound complex that can inactivate Factor Va more rapidly than does soluble activated protein C. Protein S has a number of properties in common with other cofactor proteins. It has been isolated as a distinct entity from plasma, it has no known intrinsic activities, and its effect is maximal when it is bound to a lipid surface. Protein S appears to be important in the regulation of the plasma anticoagulant activity of activated protein C as well. This is supported by the lack of anticoagulant activity of activated protein C in protein S-depleted plasma and by the observation that protein S is important in the species specificity of the anticoagulant activity of the enzyme. Future work in this area is needed to ascertain if there are any clinical manifestations of protein S deficiencies that correlate with the cofactor activity that has been established.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6234659     DOI: 10.1055/s-2007-1004415

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  25 in total

Review 1.  Guidelines on the investigation and management of thrombophilia. The British Committee for Standards in Haematology.

Authors: 
Journal:  J Clin Pathol       Date:  1990-09       Impact factor: 3.411

Review 2.  The interaction between complement component C4b-binding protein and the vitamin K-dependent protein S forms a link between blood coagulation and the complement system.

Authors:  M Hessing
Journal:  Biochem J       Date:  1991-08-01       Impact factor: 3.857

Review 3.  Gamma-carboxyglutamate-containing proteins and the vitamin K-dependent carboxylase.

Authors:  C Vermeer
Journal:  Biochem J       Date:  1990-03-15       Impact factor: 3.857

4.  Anti-human protein S antibody induces tissue factor expression through a direct interaction with platelet phosphofructokinase.

Authors:  Changyi Chen; Dan Liao; Jing Wang; Zhengdong Liang; Qizhi Yao
Journal:  Thromb Res       Date:  2013-11-16       Impact factor: 3.944

5.  Activated protein C light chain provides an extended binding surface for its anticoagulant cofactor, protein S.

Authors:  José A Fernández; Xiao Xu; Ranjeet K Sinha; Laurent O Mosnier; Michel F Sanner; John H Griffin
Journal:  Blood Adv       Date:  2017-08-07

6.  Similar hypercoagulable state and thrombosis risk in type I and type III protein S-deficient individuals from families with mixed type I/III protein S deficiency.

Authors:  Elisabetta Castoldi; Lisbeth F A Maurissen; Daniela Tormene; Luca Spiezia; Sabrina Gavasso; Claudia Radu; Tilman M Hackeng; Jan Rosing; Paolo Simioni
Journal:  Haematologica       Date:  2010-04-26       Impact factor: 9.941

7.  The effect of phospholipids on the activation of protein C by the human thrombin-thrombomodulin complex.

Authors:  J M Freyssinet; J Gauchy; J P Cazenave
Journal:  Biochem J       Date:  1986-08-15       Impact factor: 3.857

8.  Activation of human protein C by blood coagulation factor Xa in the presence of anionic phospholipids. Enhancement by sulphated polysaccharides.

Authors:  J M Freyssinet; M L Wiesel; L Grunebaum; J M Pereillo; J Gauchy; S Schuhler; G Freund; J P Cazenave
Journal:  Biochem J       Date:  1989-07-15       Impact factor: 3.857

9.  Risk factors for thrombosis in lupus patients.

Authors:  P Hasselaar; R H Derksen; L Blokzijl; M Hessing; H K Nieuwenhuis; B N Bouma; P G De Groot
Journal:  Ann Rheum Dis       Date:  1989-11       Impact factor: 19.103

10.  A simplified functional assay for protein C in plasma samples.

Authors:  W Thiel; K T Preissner; U Delvos; G Müller-Berghaus
Journal:  Blut       Date:  1986-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.